Literature DB >> 16389642

Determination of rosuvastatin in rat plasma by HPLC: Validation and its application to pharmacokinetic studies.

Thammera Ranjith Kumar1, Nikhil R Shitut, Pasikanti Kishore Kumar, Menon C A Vinu, Venkata V Pavan Kumar, Ramesh Mullangi, Nuggehally R Srinivas.   

Abstract

A specific, accurate, precise and reproducible high-performance liquid chromatography (HPLC) method was developed for the estimation of rosuvastatin (RST), a novel, synthetic and potent HMG-CoA inhibitor in rat plasma. The assay procedure involved simple liquid-liquid extraction of RST and internal standard (IS, ketoprofen) from a small plasma volume directly into acetonitrile. The organic layer was separated and evaporated under a gentle stream of nitrogen at 40 degrees C. The residue was reconstituted in the mobile phase and injected onto a Kromasil KR 100-5C18 column (4.6 x 250 mm, 5 microm). Mobile phase consisting of 0.05 m formic acid and acetonitrile (55:45, v/v) was used at a flow rate of 1.0 mL/min for the effective separation of RST and IS. The detection of the analyte peak was achieved by monitoring the eluate using a UV detector set at 240 nm. The ratio of peak area of analyte to IS was used for quantification of plasma samples. Nominal retention times of RST and IS were 8.6 and 12.5 min, respectively. The standard curve for RST was linear (r2 > 0.999) in the concentration range 0.02-10 microg/mL. Absolute recoveries of RST and IS were 85-110 and >100%, respectively, from rat plasma. The lower limit of quantification (LLOQ) of RST was 0.02 microg/mL. The inter- and intra-day precisions in the measurement of quality control (QC) samples, 0.02, 0.06, 1.6 and 8.0 microg/mL, were in the range 7.24-12.43% relative standard deviation (RSD) and 2.28-10.23% RSD, respectively. Accuracy in the measurement of QC samples was in the range 93.05-112.17% of the spiked nominal values. Both analyte and IS were stable in the battery of stability studies, viz. benchtop, autosampler and freeze-thaw cycles. RST was found to be stable for a period of 30 days on storage at -80 degrees C. The application of the assay to determine the pharmacokinetic disposition after a single oral dose to rats is described. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389642     DOI: 10.1002/bmc.611

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  7 in total

1.  The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats.

Authors:  Jin-Hua Wen; Yu-Qing Xiong
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-30       Impact factor: 2.441

2.  Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma.

Authors:  Ibrahim A Darwish; Abdul-Rahman M Al-Obaid; Hamoud A Al-Malaq
Journal:  Chem Cent J       Date:  2011-07-05       Impact factor: 4.215

3.  Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Rosuvastatin and Related Substances in Pharmaceutical Dosage Form.

Authors:  Harshal Kanubhai Trivedi; Mukesh C Patel
Journal:  Sci Pharm       Date:  2012-03-26

4.  Oral Bioavailability Improvement of Tailored Rosuvastatin Loaded Niosomal Nanocarriers to Manage Ischemic Heart Disease: Optimization, Ex Vivo and In Vivo Studies.

Authors:  Kun Liao; Na Tang; Qiang Liu; Jing Xu
Journal:  AAPS PharmSciTech       Date:  2021-01-27       Impact factor: 4.026

5.  TLC-spectrodensitometric method for simultaneous determination of dapagliflozin and rosuvastatin in rabbit plasma: stability indicating assay and kinetic studies.

Authors:  Noha S Abbas; Sayed M Derayea; Mahmoud A Omar; Gamal A Saleh
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

6.  Pharmacokinetic and pharmacodynamic interaction of Rosuvastatin calcium with guggulipid extract in rats.

Authors:  Mohammed Asad; Syed Mohammed Basheeruddin Asdaq; Yahya Mohzari; Ahmed Alrashed; Hamdan Najib Alajami; Awad Othman Aljohani; Abdullah Ali Al Mushtawi; Assil Najib Alajmi; Hanan Nageeb Alajmi; Mohd Imran; Raha Orfali
Journal:  Saudi J Biol Sci       Date:  2021-03-14       Impact factor: 4.219

7.  Validated high-performance liquid chromatographic method for the estimation of rosuvastatin calcium in bulk and pharmaceutical formulations.

Authors:  Safwan Ashour; Soulafa Omar
Journal:  Int J Biomed Sci       Date:  2011-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.